CoChat

Dosing guidance for intravenous colistin in critically-ill patients.

Open access
Nation, Roger L., Garonzik, Samira M., Thamlikitkul, Visanu, Giamarellos-Bourboulis, Evangelos J., Forrest, Alan, Paterson, David L., Li, Jian, Silveira, Fernanda P. · 2017 · Clinical Infectious Diseases

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Abstract

Background.: Intravenous colistin is difficult to use because plasma concentrations for antibacterial effect overlap those causing nephrotoxicity, and there is large interpatient variability in pharmacokinetics. The aim was to develop dosing algorithms for achievement of a clinically desirable average steady-state plasma colistin concentration (Css,avg) of 2 mg/L. Methods.: Plasma concentration-time data from 214 adult critically ill patients (creatinine clearance, 0–236 mL/min; 29 receiving renal replacement therapy [RRT]) were subjected to population pharmacokinetic analysis. Development of an algorithm for patients not receiving RRT was based on the relationship between the dose of colistimethate that would be needed to achieve a desired Css,avg and creatinine clearance. The increase in colistin clearance when patients were receiving RRT was determined from the population analysis and guided the supplemental dosing needed. To balance potential antibacterial benefit against risk of nephrotoxicity the algorithms were designed to achieve target attainment rates of >80% for Css,avg ≥2 and <30% for Css,avg ≥4 mg/L. Results.: When algorithm doses were applied back to individual patients not receiving RRT (including those prescribed intermittent dialysis on a nondialysis day), >80% of patients with creatinine clearance <80 mL/min achieved Css,avg ≥2 mg/L, but for patients with creatinine clearance ≥80 mL/min, the target attainment was <40%, even with the maximum allowed daily dose of 360 mg colistin base activity. For patients receiving RRT, target attainment rates were >80% with the proposed supplemental dosing. In all categories of patients, <30% of patients attained Css,avg ≥4 mg/L. Conclusions.: The project has generated clinician-friendly dosing algorithms and pointed to circumstances in which intravenous monotherapy may be inadequate.

Overview

Integrity signals

Registry

Crossref · 10.1093/cid/ciw839

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 27 references

Research works printed but not linked: 2

  1. Forrest, Toxicodynamics for colistin-associated changes in creatinine clearance. Presented at: Interscience Conference on Antimicrobial Agents and Chemotherapy; 5–9 September 2014
  2. European Medicines Agency, Annex III: amendments to relevant sections of the summary of product characteristics and the package leaflets

Cited by

See all 273

Metadata

Authors
Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P.
Affiliations
  • Monash University (AU)
  • School of Pharmacy and Pharmaceutical Sciences, State University of New York at Buffalo 3 ;
  • Siriraj Hospital (TH)
  • Fourth Department of Internal Medicine, University of Athens 6 Medical School ,
  • University at Buffalo, State University of New York (US)
  • The University of Queensland (AU)
  • University of Pittsburgh Medical Center (US)
Venue
Clinical Infectious Diseases
Published
2016-12-23
Volume
64
Issue
5
Pages
565-571
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2566638444
Cited by
262
References
27
Citations by year
2026: 13 · 2025: 21 · 2024: 18 · 2023: 17 · 2022: 31 · 2021: 27 · 2020: 42 · 2019: 42 · 2018: 27 · 2017: 23
FWCI
24.82
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R01AI070896)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Antibiotics Pharmacokinetics and Efficacy
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
Keywords
colistin, intravenous administration, dosing algorithm, critically ill patients, nephrotoxicity, population pharmacokinetics, creatinine clearance, renal replacement therapy, colistimethate, steady-state plasma concentration, antibiotic dosing
MeSH terms
Adult, Aged, Aged, 80 and over, Anti-Bacterial Agents, Colistin, Female, Humans, Male, Middle Aged, Pilot Projects, Critical Illness, Practice Guidelines as Topic, Renal Replacement Therapy, Young Adult, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dosing guidance for intravenous colistin in critically-ill patients. https://app.cochat.ai/papers/10.1093/cid/ciw839
The paper
Nation, R. L., Garonzik, S. M., Thamlikitkul, V., Giamarellos-Bourboulis, E. J., Forrest, A., Paterson, D. L., Li, J., & Silveira, F. P. (2017). Dosing guidance for intravenous colistin in critically-ill patients. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciw839

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.